Cancer Drug Gleevec Shows Potential for Treatment of RA
New research shows that Gleevec, a cancer drug used to treat chronic myelogenous leukemia (CLL) and certain types of stomach tumors, also has potential as a treatment for autoimmune diseases such as rheumatoid arthritis. Stanford University researchers published their findings online Sept. 14 issue of the Journal of Clinical Investigation. The... Read more








